The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic value of ctDNA monitoring in patients with resectable pancreatic ductal adenocarcinoma during surveillance.
 
Elishama Kanu
No Relationships to Disclose
 
Austin Eckhoff
No Relationships to Disclose
 
Ash Fletcher
No Relationships to Disclose
 
Ethan Agritelley
No Relationships to Disclose
 
Julia Button
No Relationships to Disclose
 
Jiayin Bao
No Relationships to Disclose
 
Michael Khayat
Employment - Natera
Stock and Other Ownership Interests - Natera
 
Erik Spickard
Employment - Natera
Stock and Other Ownership Interests - Natera
Travel, Accommodations, Expenses - Natera
 
Arkarachai Fungtammasan
Employment - Natera
Stock and Other Ownership Interests - Natera
Travel, Accommodations, Expenses - Natera
 
Rama S. Madhurapantula
Employment - Natera
Stock and Other Ownership Interests - Natera
Travel, Accommodations, Expenses - Natera
 
Shruti Sharma
Employment - Natera
Stock and Other Ownership Interests - Natera
 
Vasily Aushev
Employment - Natera
Stock and Other Ownership Interests - Natera
Travel, Accommodations, Expenses - Natera
 
Robert Lentz
Consulting or Advisory Role - Agenus (Inst); Boehringer Ingelheim (Inst); Merck (Inst); Natera (Inst)
Research Funding - ALX Oncology (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Experimental Drug Development Centre (EDDC)/A*STAR (Inst); Guardant Health (Inst); Lilly (Inst); Merck (Inst)
(OPTIONAL) Uncompensated Relationships - KAHR Medical
 
Minetta Liu
Employment - Natera
Stock and Other Ownership Interests - Natera
 
Daniel Nussbaum
No Relationships to Disclose
 
Peter Allen
Consulting or Advisory Role - Sanofi
Research Funding - Novartis